These mutual funds consistently outperform general equity schemes – Should you invest?

An examination of 25 multi-asset funds has shown they have surpassed the performance of most general equity schemes over one, three, and five-year periods. These funds are distinguished by their ability to generate competitive returns across various asset classes, offering a diversified investment strategy that is often absent in single-asset equity funds, as per a report from Ventura Securities.

The growing appeal of Multi Asset Allocation Funds can be attributed to their capacity for diversification, potential tax advantages, and superior risk-adjusted returns.

“Certain Multi Asset Allocation Funds have outperformed the majority of equity schemes, highlighting the advantages these funds can offer. The analysis conducted by Ventura Securities emphasizes the significant benefits of multi-asset funds, including strong returns. These funds present appealing choices for investors aiming for a balanced risk-reward profile. Nevertheless, the differences in performance highlight the necessity of choosing funds that align with individual investment goals and risk tolerance, reinforcing the idea that a uniform approach is not suitable for all in multi-asset allocation,” says Juzer Gabajiwala, Director at Ventura Securities Ltd.

Also Read: NPS Calculator: How much to save in NPS today for a Rs 1.5 lakh monthly pension post retirement?

Performance of select Multi Asset Allocation Funds and the percentage of equity schemes, each has outperformed

The Multi Asset Fund from Quant AMC has shown a notable performance, outperforming approximately 79% of equity schemes based on its 3-year returns and 86% over a 5-year period. Its allocation strategy, despite a controlled equity exposure of less than 51%, has proven successful in surpassing the returns of numerous equity funds. ICICI Prudential Multi Asset excelled, outperforming 63% of equity schemes’ returns over a 3-year period and nearly 50% over a 5-year timeframe.

No. of Equity Schemes [1 Year: 640, 3 Years: 458 & 5 Years: 366]

Asset Allocation strategies across all 25 Multi Asset Allocation Funds

The allocation strategies that exist across 25 multi-asset allocation funds show a huge variation, heavy on equity and debt along with a mix of gold and silver, arbitrage and other alternative assets. This diversity underscores the fact that ‘one size does not fit all’ as each fund follows a distinct strategy tailored to different market conditions and investor objectives.

Some funds have outperformed large-cap funds by delivering higher returns with lower associated risk.

 » Read More

Related Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

Pharma major Mankind Pharma on Thursday reported its financial results for the third quarter and nine months ended 31 st December 2024. The company reported revenue from Operations at Rs. 3,230 Cr, up by 24% YoY and domestic revenue at INR 2,773 Cr, up 17%, Exports at INR 457 Cr, up 121% YoY. The company’s